Amanote Research

Amanote Research

    RegisterSign In

The Pointy End of Point-Of-Care Testing for Direct Oral Anticoagulants

Thrombosis and Haemostasis - Germany
doi 10.1055/s-0039-1700874
Full Text
Open PDF
Abstract

Available in full text

Categories
Hematology
Date

November 21, 2019

Authors
Emmanuel J. FavaloroGiuseppe Lippi
Publisher

Georg Thieme Verlag KG


Related search

Direct Oral Anticoagulants (DOACs)

Vascular Medicine
MedicineCardiovascular MedicineCardiology
2015English

Direct Oral Anticoagulants: First Airbag

Medical Council
2019English

A New Generation of Oral Direct Anticoagulants

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2012English

Bleeding Complications From the Direct Oral Anticoagulants

BMC Hematology
HematologyMolecular Biology
2015English

The Reversal of Direct Oral Anticoagulants in Animal Models

Shock
Critical CareEmergency MedicineIntensive Care Medicine
2017English

Reversal of Direct Oral Anticoagulants in Hemophilia Treatment

Memo - Magazine of European Medical Oncology
OncologyHematology
2016English

Novel Methods for Assessing Oral Direct Factor Xa and Thrombin Inhibitors: Use of Point-Of-Care Testing and Urine Samples

Seminars in Thrombosis and Hemostasis
Cardiovascular MedicineHematologyCardiology
2012English

Reversal of Direct Oral Anticoagulants: Guidance From the Anticoagulation Forum

American Journal of Hematology
Hematology
2019English

Direct Oral Anticoagulants (DOAC) in Oral Implant Surgery - A Metaanalysis

Clinical Oral Implants Research
Oral Surgery
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy